Publications 2009

Bass, Adam J; Watanabe, Hideo; Mermel, Craig; Yu, Soyoung; Perner, Sven; Verhaak, Roel G; Kim, So Young; Tamayo, P; Gat-Viks, I; Ramos, AH; Woo, MS; Weir, BA; Getz, G; Beroukim, R; O'Kelly, M; Dutt, A; Rosenblatt-Rosen, O; Dziunycz, P; Komisarof, J; Chirieac, LR; LaFargue, CJ; Scheble, V; Wilbertz, T; Ma, C; Rao, S; Nakagawa, H; Stairs, DB; Lin, L; Giordiano, TJ; Wagner, P; Minna, JD; Gazdar, AF; Zhu, CQ; Brose, MS; Cecconello, I; Ribeiro Jr, U; Marie, SK; Dahl, Olav; Shivdasani, RA; Tsao, MS; Rubin, MA; Wong, KK; Regev, A; Hahn, WC; Beer, DG; Rustgi, AK; Meyerson, M.
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics 2009 ;Volum 41.(11) s. 1238-1242

Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein.
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. International Journal of Hyperthermia 2009 ;Volum 25.(1) s. 41-46

Borkamo, Erling Dahl; Schem, Baard-Christian; Fluge, Øystein; Bruland, Ove; Dahl, Olav; Mella, Olav.
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics 2009 ;Volum 75.(5) s. 1562-1569

 

Bruheim, K; Guren, MG; Skovlund, E; Hjermstad, Marianne Jensen; Dahl, O; Frykholm, Gunilla; Carlsen, Erik; Tveit, KM.
Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics 2009 ;Volum 17.

 

Bruland, Ove; Fluge, Øystein; Akslen, Lars A.; Eiken, Hans Geir; Lillehaug, Johan R.; Varhaug, Jan Erik; Knappskog, Per Morten.
Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas. BMC Cancer 2009 ;Volum 9. s. 425-

 

Brunsvig, PF; Sundstrom, S; Aasebo, U; Bremnes, R; Hansen, O; Helle, SI; Grønberg, Bjørn H.; Ryberg, M; Soerensen, BT; Rytter, C; Heikkila, R; Aamdal, S.
A phase III study of radiation therapy with concurrent docetaxel versus radiation therapy alone in patients with non-small cell lung cancer stage IIIA/B. Journal of Thoracic Oncology 2009 ;Volum 4.(9) s. S517-S517

 

Brydøy, Marianne; Oldenburg, Jan; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik A.; Wentzel-Larsen, Tore; Hauge, Erik Rønneberg; Dahl, Olav; Fosså, Sophie Dorothea.
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. Journal of the National Cancer Institute 2009 ;Volum 101.(24) s. 1682-1695

 

Christoffersen, Thoralf; Guren, Tormod K.; Spindler, Karen-Lise Garm; Dahl, Olav; Lønning, Per Eystein; Gjertsen, Bjørn Tore.
Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. European Journal of Pharmacology 2009 ;Volum 625.(1-3) s. 6-22

Dahl, Olav.
Follow up your unexpected clinical observations!. Acta Oncologica 2009 ;Volum 48.(3) s. 325-327

Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N.; Myrvold, Helge E.; Vonen, Barthold; Podhorny, Nina; Bjerkeset, Ottar; Eide, Tor Jack; Halvorsen, Tore B.; Tveit, Kjell Magne.
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica 2009 ;Volum 48.(3) s. 368-376

Eikesdal, Hans Petter; Kalluri, Raghu.
Drug resistance associated with antiangiogenesis therapy. Seminars in Cancer Biology 2009 ;Volum 19.(5) s. 310-317

 

 

Fluge, Øystein; Gravdal, Karsten; Carlsen, Erik; Vonen, Barthold; Kjellevold, Kjell-Henning; Refsum, Sigvald; Lilleng, Rune; Eide, Tor Jacob; Halvorsen, Tore B.; Tveit, Kjell Magne; Otte, Ariel P.; Akslen, Lars A.; Dahl, Olav.
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer 2009 ;Volum 101.(8) s. 1282-1289

 

Fluge, Øystein; Mella, Olav.
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurology 2009 ;Volum 9. s. 28

 

Flågeng, Marianne Hauglid; Moi, Line Leonore Haugan; Dixon, J. Michael; Geisler, Jürgen; Lien, Ernst Asbjørn; Miller, William R.; Lønning, Per Eystein; Mellgren, Gunnar.
Nuclear receptor coactivators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer. 2009 Oct 20;101(8):1253-60.

Glynn, Sharon A.; Boersma, Brenda J.; Howe, Tiffany M.; Edvardsen, Hege; Geisler, Stephanie; Goodman, Julie E.; Ridnour, Lisa A.; Lønning, Per Eystein; Børresen-Dale, Anne-Lise; Naume, Bjørn; Kristensen, Vessela Nedelcheva; Chanock, Stephen J.; Wink, David A.; Ambs, Stefan.
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clinical Cancer Research 2009 ;Volum 15.(12) s. 4165-4173

Grov, Ellen Karine; Fosså, Sophie Dorothea; Bremnes, Roy M.; Dahl, Olav; Klepp, Olbjørn; Wist, Erik; Dahl, Alv Andreas.
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors. Acta Oncologica 2009 ;Volum 48.(6) s. 842-849

Haldorsen, Ingfrid Salvesen; Kråkenes, Jostein; Krossnes, Bård Kronen; Mella, Olav; Espeland, Ansgar.
CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. American Journal of Neuroradiology 2009 ;Volum 30.(4) s. 744-751

Hans, Volkmar; Evans, Dean B.; Lønning, Per Eystein; Geisler, Jurgen.
Proteomics analysis of tissue samples obtained before and during letrozole treatment in postmenopausal patients with locally advanced breast cancer. Cancer Research 2009 ;Volum 69.(2) s. 214S-214S

Hauglid, Marianne; Moi, Line Leonore Haugan; Dixon, J. Michael; Geisler, Jurgen; Lien, Ernst Asbjørn; Miller, William Russell; Lønning, Per Eystein; Mellgren, Gunnar.
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. British Journal of Cancer 2009 ;Volum 101.(8) s. 1253-1260

Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie Dorothea; Dahl, Olav; Brydøy, Marianne; Aasebø, Ulf; Wilsgaard, Tom; Bremnes, Roy M..
Pulmonary function in long-term survivors of testicular cancer. Journal of Clinical Oncology 2009 ;Volum 27.(17) s. 2779-2786

Haynes, B; Straume, Anne Hege; Geisler, Jurgen; Ahern, R; Lønning, Per Eystein; Dowsett, M.
DETERMINANTS OF INTRATUMOURAL OESTRADIOL (E2) CONCENTRATIONS IN POSTMENOPAUSAL BREAST CANCER: ROLES FOR OESTROGEN RECEPTOR (ER) AND 17B-HYDROXYSTEROID DEHYDROGENASE 7 (HSD17B7). Annals of Oncology 2009 ;Volum 20. s. 51-52

Jullumstrø, Eivind; Lydersen, Stian; Møller, Bjørn; Dahl, Olav; Edna, Tom-Harald.
Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. European Journal of Cancer 2009 ;Volum 45.(13) s. 2383-2390

Karlsdóttir, Ása; Muren, Ludvig Paul; Wentzel-Larsen, Tore; Johannessen, Dag Clement; Haukaas, Svein Andreas; Halvorsen, Ole Johan; Dahl, Olav.
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. Acta Oncologica 2009 ;Volum 48.(6) s. 874-881

Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav.
Topographical distribution of choroidal naevi in the ocular fundus. Eye (London. 1987) 2009 ;Volum 23.(8) s. 1685-1690

Lønning, Per Eystein.
Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?. European Journal of Cancer 2009 ;Volum 45.(4) s. 527-535

Lønning, Per Eystein.
Additive endocrine therapy for advanced breast cancer - back to the future. Acta Oncologica 2009 ;Volum 48.(8) s. 1092-1101

Lønning, Per Eystein.
Molecular classes of breast cancer and their clinical relevance. Current Breast Cancer Reports 2009 ;Volum 1.(4) s. 183-189

Lønning, Per Eystein.
Tailored targeted therapy for all: a realistic and worthwhile objective? Breast Cancer Research 2009 ;Volum 11. Suppl. 3 s. 1-5

Lønning, Per Eystein; Helle, Hildegunn; Duong, Nhat Kim; Ekse, Dagfinn; Aas, T; Geisler, Jurgen.
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. Journal of Steroid Biochemistry and Molecular Biology 2009 ;Volum 117.(1-3) s. 31-41

Overgaard, Jens; Gonzalez Gonzalez, D; Hulshof, M.C.C.H.; Arcangeli, G; Dahl, Olav; Mella, Olav; Bentzen, SM.
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. International Journal of Hyperthermia 2009 ;Volum 25.(5) s. 323-334

Røsland, Gro Vatne; Svendsen, Agnete; Torsvik, Anja; Sobala, Ewa; McCormack, Emmet Martin; Immervoll, Heike; Mysliwietz, Josef; Tonn, Jörg Christian; Goldbrunner, Roland; Lønning, Per Eystein; Bjerkvig, Rolf; Schichor, Christian.
Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Research 2009 ;Volum 69.(13) s. 5331-5339

Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav; Skarstein, Arne; Søreide, Jon Arne.
Rectal cancer with macroscopic peritoneal involvement - clinical challenges and

consequences. Colorectal Disease 2009 ;Volum 11.(8) s. 838-844

Sigurdsson, Helgi Kjartan; Søreide, Jon Arne; Dahl, Olav; Skarstein, Arne; von Hofacker, Sebastian; Kørner, Hartwig.
Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. Acta Oncologica 2009 ;Volum 48.(3) s. 377-384

Skaali, Tone; Fosså, Sophie Dorothea; Bremnes, Roy; Dahl, Olav; Haaland, Carl Fredrik; Hauge, Erik Rønneberg; Klepp, Olbjørn; Oldenburg, Jan; Wist, Erik; Dahl, Alv Andreas.
Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology 2009 ;Volum 18.(6) s. 580-588

 

Sorbye H, Pfeiffer P, Cavalli-Björkman N, Qvortrup C, Holsen MH, Wentzel-Larsen T, Glimelius B.

Clinical trial enrolment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients

Cancer. 2009 Oct 15;115(20):4679-87.

Tandstad, Torgrim; Dahl, Olav; Cohn-Cedermark, Gabriella; Cavellin-Ståhl, Eva; Stierner, Ulrika; Solberg, Arne; Langberg, Carl; Bremnes, Roy M.; Laurell, Anna; Wijkstrøm, Hans; Klepp, Olbjørn.
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program. Journal of Clinical Oncology 2009 ;Volum 27.(13) s. 2122-2128